[HTML][HTML] Prognostic value of cardiovascular biomarkers in COVID-19: a review
M Aboughdir, T Kirwin, A Abdul Khader, B Wang - Viruses, 2020 - mdpi.com
In early December 2019, the coronavirus disease (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged in Wuhan, China. As of
May 10th, 2020, a total of over 4 million COVID-19 cases and 280,000 deaths have been
reported globally, reflecting the raised infectivity and severity of this virus. Amongst
hospitalised COVID-19 patients, there is a high prevalence of established cardiovascular
disease (CVD). There is evidence showing that COVID-19 may exacerbate cardiovascular …
respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged in Wuhan, China. As of
May 10th, 2020, a total of over 4 million COVID-19 cases and 280,000 deaths have been
reported globally, reflecting the raised infectivity and severity of this virus. Amongst
hospitalised COVID-19 patients, there is a high prevalence of established cardiovascular
disease (CVD). There is evidence showing that COVID-19 may exacerbate cardiovascular …
以上显示的是最相近的搜索结果。 查看全部搜索结果